WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Answers_B-lymphocytes, B-lymphocytes location circulate back and forth between the blood and the lymphoid system of the body, effector T4-lymphocyte producing cytokines that interact with that B-lymphocyte examples of effector T4 cells TFH cells, molecules of that unique antibody are placed on the surface of the B-lymphocyte where they can function as B-cell receptors activation initial activation of a naive B-lymphocyte occurs when B-cell receptors on the surface of the B-lymphocyte bind epitopes of an exogenous antigen having a corresponding shape., effector T4-lymphocyte producing cytokines that interact with that B-lymphocyte examples of effector T4 cells TH1 cells, B-lymphocytes maturation each B-lymphocyte becomes genetically programmed through a series of gene-splicing reactions to produce an antibody molecule with a unique specificity for binding a specific epitope, effector T4-lymphocyte producing cytokines that interact with that B-lymphocyte action of cytokines enable antibody producing cells to switch the class or isotype of antibodies, effector T4-lymphocyte producing cytokines that interact with that B-lymphocyte examples of effector T4 cells TH2 cells, each B-lymphocyte becomes genetically programmed through a series of gene-splicing reactions to produce an antibody molecule with a unique specificity for binding a specific epitope subsequently molecules of that unique antibody are placed on the surface of the B-lymphocyte where they can function as B-cell receptors, initial activation of a naive B-lymphocyte occurs when B-cell receptors on the surface of the B-lymphocyte bind epitopes of an exogenous antigen having a corresponding shape. then the antigen is engulfed, placed in a phagosome, and degraded with lysosomes, each B-lymphocyte becomes genetically programmed through a series of gene-splicing reactions to produce an antibody molecule with a unique specificity for binding a specific epitope B-lymphocyte clones The body produces 10,000,000 or more distinct clones of T-lymphocytes, each with a unique T-cell receptor, effector T4-lymphocyte producing cytokines that interact with that B-lymphocyte action of cytokines stimulate activated B-lymphocytes to synthesize and secrete antibodies, the antigen is engulfed, placed in a phagosome, and degraded with lysosomes then peptide epitopes are bound to MHC-II molecules and placed on the surface of the B-lymphocyte, MHC-II/peptide complexes can then be recognized by complementary shaped T-cell receptors (TCRs) and CD4 molecules on an effector T4-lymphocytes result effector T4-lymphocyte producing cytokines that interact with that B-lymphocyte, peptide epitopes are bound to MHC-II molecules and placed on the surface of the B-lymphocyte antigen-presentation MHC-II/peptide complexes can then be recognized by complementary shaped T-cell receptors (TCRs) and CD4 molecules on an effector T4-lymphocytes, effector T4-lymphocyte producing cytokines that interact with that B-lymphocyte action of cytokines enable activated B-lymphocytes to proliferate, effector T4-lymphocyte producing cytokines that interact with that B-lymphocyte action of cytokines promote the differentiation of B-lymphocytes into antibody-secreting plasma cells as well as B-memory lymphocytes
